Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Kasztanowa 3, 41-200 Sosnowiec, Poland.
"Biochefa" Pharmaceutical Research and Production Plant, Kasztanowa 3, 41-200 Sosnowiec, Poland.
Molecules. 2020 May 7;25(9):2185. doi: 10.3390/molecules25092185.
Transplantation is currently a routine method for treating end-stage organ failure. In recent years, there has been some progress in the development of an optimal composition of organ preservation solutions, improving the vital functions of the organ and allowing to extend its storage period until implantation into the recipient. Optimizations are mostly based on commercial solutions, routinely used to store grafts intended for transplantation. The paper reviews hormones with a potential nephroprotective effect, which were used to modify the composition of renal perfusion and preservation solutions. Their effectiveness as ingredients of preservation solutions was analysed based on a literature review. Hormones and trophic factors are innovative preservation solution supplements. They have a pleiotropic effect and affect normal renal function. The expression of receptors for melatonin, prolactin, thyrotropin, corticotropin, prostaglandin E1 and trophic factors was confirmed in the kidneys, which suggests that they are a promising therapeutic target for renal IR (ischemia-reperfusion) injury. They can have anti-inflammatory, antioxidant and anti-apoptotic effects, limiting IR injury.
移植目前是治疗终末期器官衰竭的常规方法。近年来,在开发最佳器官保存液组成方面取得了一些进展,改善了器官的生命功能,并允许将其储存期延长至植入受体。优化主要基于商业解决方案,这些解决方案通常用于储存用于移植的移植物。本文综述了具有潜在肾保护作用的激素,这些激素被用于修改肾灌注和保存液的组成。根据文献回顾分析了它们作为保存液成分的有效性。激素和营养因子是创新的保存液补充剂。它们具有多效性,影响正常肾功能。在肾脏中证实了褪黑素、催乳素、促甲状腺素、促肾上腺皮质激素、前列腺素 E1 和营养因子的受体表达,这表明它们是肾 IR(缺血再灌注)损伤的有前途的治疗靶点。它们具有抗炎、抗氧化和抗细胞凋亡作用,限制了 IR 损伤。